# Effect of Duolac 7S Administration on Improving Symptom in Irritable Bowel Syndrome

> **NCT01088971** · PHASE3 · COMPLETED · sponsor: **Cell Biotech Co., Ltd.** · enrollment: 60 (actual)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Duolac7S
- **DIETARY_SUPPLEMENT:** starch

## Key facts

- **NCT ID:** NCT01088971
- **Lead sponsor:** Cell Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2011-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01088971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01088971, "Effect of Duolac 7S Administration on Improving Symptom in Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01088971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*